A comparison between the novel rabbit monoclonal antibodies (SP1 and B644) and mouse antibodies for evaluating estrogen receptor in breast tumors

Jornal Brasileiro de Patologia e Medicina Laboratorial

Volumn 43, Issue 6, 2007, Pages 435-440

  Rocha, Rafael Malagoli ^a   Nunes, Cristiana Buzelin ^a   Rocha, Gislene Fátima Silva ^b   Oliveira, Flávio Nepomuceno ^c   Sanches, Fernanda Squárcio Fernandes ^d   Gobbi, Helenice ^e  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Ministério de Ciência Tecnologia e Inovação Salvador

^c CNPq ^*

^d Fundacao de Amparo a Pesquisa do Estado de Minas Gerais FAPEMIG   (Brazil)

^e UFMG

Author keywords

Breast cancer; Immunohistochemistry; Monoclonal antibodies

Indexed keywords

EID: 41549094655     PISSN: 16762444     EISSN: 16784774     Source Type: Journal    
DOI: 10.1590/S1676-24442007000600008     Document Type: Article

References (28)

1. Anderson, J.; Poulsen, H. S. Immunohistochemical estrogen receptor determination in paraffin-embedded tissue: prediction of response to hormonal treatment in advanced breast cancer. Cancer, v. 64, p. 1901-89, 1908.
2. Barnes, D. M. et al. Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. Br J Cancer, v. 74, p. 1445-51, 1996.
3. Cano, G. et al. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2. Diagn Cytopathol, v. 29, n. 4, p. 207-11, 2003.
4. Cheang, M. C. et al. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival. J Clin Oncol, v. 24, n. 36, p. 5626-8, 2006.
5. Chebil, G. et al. Estrogen and progesterone receptor assay in paraffin-embedded breast cancer - reproducibility of assessment. Acta Oncol, v. 43, n. 1, p.43-7, 2003.
6. Cheuk, W. et al. Consistent immunostaining for cyclin D1 can be achieved on a routine basis using a newly available rabbit monoclonal antibody. Am J Surg Pathol, v. 28, n. 6, p. 801-7, 2004.
7. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer: Adopted on May 17, 1996 by the American Society of Clinical Oncology. J Clin Oncol, v. 14, p. 2843-77, 1996.
8. Fitzgibbons, P. L. et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med, v. 124, p. 966-78, 2000.
9. McLaren, B. K. et al. Loss of expression of transforming growth factor beta type II receptor correlates with high tumor grade in human breast in situ and invasive carcinomas. Am J Surg Pathol, v. 29, n. 1, p. 105-8, 2005.
10. Gobbi, H. et al. Breast cancer risk associated with estrogen receptor expression in epithelial hyperplasia lacking atypia and adjacent lobular units. Int J Cancer, v. 113, p. 857-9, 2005.
11. Gouvêa, A. P. et al. Her-2/ neu immunoreactivity in invasive mammary carcinomas: a comparative study using monoclonal and polyclonal antibodies including the Herceptest. J Bras Patol, v. 40, n. 1, p. 47-52, 2004.
12. Hanna, W. et al. The predictive value of ERICA in breast cancer recurrence: a univariate and multivariate analysis. Mod Pathol, v. 6, p. 748-54, 1993.
13. Harvey, J. N. et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol, v.17, p. 1474-81, 1999.
14. Huang, Z. et al . Novel rabbit monoclonal antibody to progesterone receptor (clone SP2): no heat pretreatment but effective for paraffin section immunohistochemistry. Appl Immunohistoch Mol Morphol, v. 14, p. 229-33, 2006.
15. Huang, Z. et al. Development of new rabbit monoclonal antibody to estrogen receptor: immunohistochemical assessment on formalin-fixed, paraffin-embedded tissue sections. Appl Immunohistochem Mol Morphol, v. 13, p. 91-5, 2005.
16. Jacobs, T. W. et al. Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst, v. 88, p. 1054-59, 1996.
17. McGuire, W. L. Breast cancer prognostic factors. Evaluation guidelines. J Natl Cancer Inst, v. 83, p. 154-1, 1991.
18. Pellicer, E. M.; Sundblad, A. Evaluation antibodies to estrogen receptors. Appl Immunohistochem, v. 2, p. 141, 1994.
19. Pertschuk, L. P. et al. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays. Cancer, v. 77, p. 2514-19, 1996.
20. Rhodes, A. et al. Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on 'in house' tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries. J Clin Pathol, v. 53, p. 292, 2000.
21. Rhodes, A. et al. Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Am J Clin Pathol, v. 115, p. 44-58, 2001.
22. Rhodes, A. et al. Evaluat ion of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumours: a comparative study involving results from laboratories in 21 countries. Am J Clin Pathol, v. 118, p. 408-17, 2002.
23. Romain, S. et al. on behalf of the EORTC Receptor Study Group. EORTC Receptor Study Group Report: steroid receptor distribution in 47, 892 breast cancers. A collaborative study of 7 European laboratories. Eur J Cancer, v. 31A, p. 411-17, 1995.
24. Rossi, S. et al. A comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies. Am J Clin Pathol, v. 124, n. 2, p. 295-302, 2005.
25. Sannino, P.; Shousha, S. Demonstration of estrogen receptors in paraffin wax sections of breast carcinoma using the monoclonal antibody 1D5 and microwave oven processing. J Clin Pathol, v. 47, p.90-2, 1994.
26. Stierer, M.; Rosen, H.; Weber, R. Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer: correlation of histopathology and prognostic factors. Ann Surg, v. 218, p. 13-21, 1993.
27. Treaba, D. O. et al. Significantly improved sensitivity for ER detection in breast cancer using a new rabbit monoclonal anti-ER antibody (SP1). Mod Pathol, v. 18, p. 53A, 2005.
28. Vassallo, J. et al. Comparison of immunoexpression of 2 antibodies for estrogen receptors (1D5 and 6F11) in breast carcinomas using different antigen retrieval and detection methods. Appl Immunohistochem, v. 12, p. 177-82, 2004.